logo-loader

Machavert Pharmaceuticals developing drugs to target hard to fight cancers

Published: 15:49 08 Jan 2019 GMT

Machavert Pharmaceuticals Jacob Staszak Jirkovsky spoke with Christine Corrado from Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The Colorado-based  bio-pharmaceutical company company develops new, first-in-class therapeutics that can harness the power of the human body to treat cancer and autoimmune diseases. The company’s primary goal is to improve the length and the quality of life of patients suffering from life threatening diseases, such as pancreatic cancer.

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

1 hour, 34 minutes ago